Home Newsfeeds Genius Brands Grows ‘Stan Lee’ Business For Centennial Celebration

News

Genius Brands Grows ‘Stan Lee’ Business For Centennial Celebration

"Stan Lee" Documentary to Premiere on Disney+ in 2023 Stan Lee Online Store Launches, Featuring a Branded Product Collection

byBenzinga Newsdesk

December 28, 2022

1 minute read

“Stan Lee” Documentary to Premiere on Disney+ in 2023

Stan Lee Online Store Launches, Featuring a Branded Product Collection

Elon Musk Is Working On Integrating iMessage, WhatsApp And Signal In One ‘Magical Kayak’

By Ananya Gairola

September 18, 3:06 AM

Elon Musk has announced his commitment to integrating iMessage, WhatsApp, and Signal into a unified messaging platform as part of his broader vision to transform X into an "everything app."

AAPL

Bulls And Bears Of The Week: Apple, Tesla, Amazon And Why Jim Cramer Turned Bearish On This Chipmaker

By Michael Cohen

September 24, 12:17 PM

Benzinga has examined the prospects for many investors' favorite stocks over the past week, here's a look at some of our top stories.

AAPL

Dow Falls Over 200 Points; ISM Manufacturing PMI Rises In March

By Avi Kapoor

April 1, 10:39 AM

U.S. stocks traded mixed this morning, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.57% to 39,580.90 while the NASDAQ rose 0.30% to 16,427.97. The S&P 500 also fell, dropping, 0.07% to 5,250.56.

AEON

Altimmune Shares Fall Despite Fatty Liver Disease Study Meets Primary Goal

By Vandana Singh

September 14, 9:25 AM

Altimmune Inc (NASDAQ:ALT) shares plunged after topline results from its 12-week Phase 1b study of pemvidutide in subjects with non-alcoholic fatty…

ALT

Genius Brands Grows ‘Stan Lee’ Business For Centennial Celebration

Related Posts

Elon Musk Is Working On Integrating iMessage, WhatsApp And Signal In One ‘Magical Kayak’

Bulls And Bears Of The Week: Apple, Tesla, Amazon And Why Jim Cramer Turned Bearish On This Chipmaker

Dow Falls Over 200 Points; ISM Manufacturing PMI Rises In March

Altimmune Shares Fall Despite Fatty Liver Disease Study Meets Primary Goal